| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/21/2006 | US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 03/21/2006 | US7015196 neurokinin receptor inhibitors comprising cyclic petides used for prophylaxis of respiratory system and urogenital disorders, as antitussive agents and muscle relaxants |
| 03/21/2006 | US7014862 Chewable compositions containing a gel-forming extract of psyllium |
| 03/21/2006 | US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/21/2006 | US7014845 copolymer of a polysaccharide and a vinyl or acrylic polymer crosslinked with a diamine, amino acid or polypeptide; sustained release; as the polysaccharide is degraded by intestinal bacteria, an active steroidal or nonsteroidal drug is released for effective absorption |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2270887C Methods and compositions for inhibition of angiogenesis |
| 03/21/2006 | CA2267251C Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists |
| 03/21/2006 | CA2177955C Use of dimeticone for treating constipation |
| 03/21/2006 | CA2072416C Cyclopropenone derivatives |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006028270A1 Rebamipide preparation for rectal administration to be prepared before using |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006028161A1 Serotonin 5-ht3 receptor agonist |
| 03/16/2006 | WO2006028122A1 Agent for preventing and ameliorating obesity |
| 03/16/2006 | WO2006028110A1 Process for producing water-soluble hyaluronic acid modification |
| 03/16/2006 | WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13 |
| 03/16/2006 | WO2006027579A2 The treatment of inflammatory disorders and pain |
| 03/16/2006 | WO2006027052A2 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 03/16/2006 | WO2006026829A1 Stable paste composition of enteric coated acid labile active agent and use thereof |
| 03/16/2006 | WO2005079778A3 Medicaments for treating barrett’s oesophagus |
| 03/16/2006 | US20060058552 Solid preferably with an aspect ratio of 1 to 4 and a solubility in water at room temperature of at least 425 mg/ml. |
| 03/16/2006 | US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease |
| 03/16/2006 | US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058348 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors |
| 03/16/2006 | US20060058329 Pyrazole inhibitors of the transforming growth factor |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058300 Intermediates of bupropion metabolites synthesis |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058288 Severe sepsis preventive therapeutic agent |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060057704 Composition |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057218 N-[1-butyl-4-piperidinylmethyl[3,4-dihydro-2 oxazino[3,2-a indole-10 carboxamide as drugs with Cahpo4 or Ca3/po4/2 fillers or binders for use in treatment of irritable bowel syndrome, urinry incontience or arrhythmias |
| 03/16/2006 | US20060057195 Stable solid preparations |
| 03/16/2006 | US20060057076 Oral humectants |
| 03/16/2006 | DE102004038328A1 Neue Verwendungen von 2-Phenyl-substituierten Imidazotriazinon-Derivaten New uses of 2-phenyl-substituted derivatives imidazotriazinone |
| 03/16/2006 | DE10116175B4 Verwendung von löslichem Stoffinventar aus Wurzeln von Salvia officinalis zur Behandlung von ulcerösen Zuständen im Magen-Darmtrakt Using soluble substance inventory from roots of Salvia officinalis for the treatment of ulcerative conditions of the gastrointestinal tract |
| 03/16/2006 | CA2579540A1 The treatment of inflammatory disorders and pain |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2578958A1 Acetylated starch or starch succinate for treatment of obesity or diabetes |
| 03/16/2006 | CA2578702A1 Method of wound healing using a2b adenosine receptor antagonists |
| 03/16/2006 | CA2578231A1 Sulpiride derivatives pharmaceutical compositions |
| 03/16/2006 | CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 03/15/2006 | EP1634953A2 Platelet-activating factor acethylhydrolase |
| 03/15/2006 | EP1634618A1 Method for identifying compounds that increase bone mineral density |
| 03/15/2006 | EP1634602A2 Use of plants of the genus Sideritis for preventing and influencing disturbances correlated with a changed serotoninergic neurotransmission |
| 03/15/2006 | EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators |
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 03/15/2006 | EP1633736A1 Barium salt of benzimidazole derivative |
| 03/15/2006 | EP1633378A2 Pediocin-producing pediococci |
| 03/15/2006 | EP1633359A1 Use of efletirizine for treating persistent allergic rhinitis |
| 03/15/2006 | EP1590004A4 Improved thickened beverages for dysphagia |
| 03/15/2006 | EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/15/2006 | EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 03/15/2006 | EP1461040B1 Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics |
| 03/15/2006 | EP1383498B1 Crf receptor antagonists |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1309589B1 Urea compounds and methods of uses |
| 03/15/2006 | EP1294893B1 Modification of hepatitis b core antigen |
| 03/15/2006 | EP1196172B1 (S,S)-Reboxetine for treating chronic pain |
| 03/15/2006 | EP1129078B1 Indazole derivatives with 5-ht2 receptor activity |
| 03/15/2006 | EP0934292B1 Metalloproteinase inhibitors |
| 03/15/2006 | EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 03/15/2006 | EP0804438B1 Tricyclic benzazepine vasopressin antagonists |
| 03/15/2006 | CN1747956A 6-substituted imidazopyrazines |
| 03/15/2006 | CN1747731A Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 03/15/2006 | CN1746288A Biological wine and production thereof |
| 03/15/2006 | CN1745848A Chitin-sodium alginate packed pylorus helicobacterium protein microballs and their preparation |
| 03/15/2006 | CN1745847A Medicine composition and method for treating hepatitis with arginase |
| 03/15/2006 | CN1745846A Dental ulcerative glue |
| 03/15/2006 | CN1745844A Chinese medicinal composition for treating chronic atrophic gastritis |
| 03/15/2006 | CN1745842A Chinese medicine for treating acute and chronic hepatitis and hepatocirrhosis, its preparation thereof |
| 03/15/2006 | CN1745827A Chinese medicinal composition for treating gastritis and constipation, its preparation and use |
| 03/15/2006 | CN1745812A Toothache paste |
| 03/15/2006 | CN1745809A Liuwei Dihuang effervescent tablet and its preparation thereof |
| 03/15/2006 | CN1745800A Preparation of Chinese medicinal composition for treating chronic atrophic gastritis |
| 03/15/2006 | CN1745799A Huoxiang Zhengqi drop pill an dits preparation |
| 03/15/2006 | CN1745794A Compound Chinese medicine for treating hypopepsia |
| 03/15/2006 | CN1745790A Chinese medicinal preparation for treating consumptive disease and its making method thereof |
| 03/15/2006 | CN1745788A Chinese preparation for treating infantile diarrhea and its making method thereof |
| 03/15/2006 | CN1745770A Compound Chinese medicine against stomachache |
| 03/15/2006 | CN1745761A Strengthening distillate |
| 03/15/2006 | CN1745750A Lansoprazole liposome and its preparation |
| 03/15/2006 | CN1745747A Use of proanthocyanidin in preparing medicine for treating colitis |
| 03/15/2006 | CN1745639A Antibacterial and sterilizing Chinese medicinal herbal products for shoe-pad |
| 03/15/2006 | CN1245398C Extraction technology of baicalein, medicinal composition and preparation technology of medicine |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |